$5.93
0.0%
Downside
Day's Volatility :6.47%
Upside
6.47%
67.5%
Downside
52 Weeks Volatility :79.92%
Upside
38.2%
Period | Nutriband Inc | Index (Russel 2000) |
---|---|---|
3 Months | 4.4% | 0.0% |
6 Months | 62.47% | 0.0% |
1 Year | 165.92% | 0.0% |
3 Years | 1.89% | -25.1% |
Market Capitalization | 68.7M |
Book Value | $0.73 |
Earnings Per Share (EPS) | -0.81 |
Wall Street Target Price | 18.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -462.5% |
Return On Assets TTM | -30.13% |
Return On Equity TTM | -60.41% |
Revenue TTM | 2.0M |
Revenue Per Share TTM | 0.24 |
Quarterly Revenue Growth YOY | -14.299999999999999% |
Gross Profit TTM | 750.4K |
EBITDA | -5.5M |
Diluted Eps TTM | -0.81 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 203.54%
Sell
Neutral
Buy
Nutriband Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Nutriband Inc | -0.67% | 62.47% | 165.92% | 1.89% | 3.41% |
![]() Regeneron Pharmaceuticals, Inc. | -18.91% | -10.03% | 3.03% | 32.07% | 171.22% |
![]() Biontech Se | -6.32% | 20.86% | 20.53% | -61.49% | 487.66% |
![]() Alnylam Pharmaceuticals, Inc. | 0.87% | 82.23% | 69.57% | 63.38% | 198.57% |
![]() Vertex Pharmaceuticals Incorporated | 1.94% | 17.73% | 25.11% | 159.71% | 136.25% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Nutriband Inc | NA | NA | NA | 0.0 | -0.6 | -0.3 | NA | 0.73 |
![]() Regeneron Pharmaceuticals, Inc. | 20.75 | 20.75 | 1.18 | 44.77 | 0.17 | 0.08 | NA | 242.47 |
![]() Biontech Se | 160.8 | NA | 0.04 | -2.76 | -0.03 | -0.02 | NA | 80.22 |
![]() Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.39 | -15.01 | 0.02 | NA | -0.02 |
![]() Vertex Pharmaceuticals Incorporated | 32.84 | NA | 1.21 | 0.16 | -0.03 | 0.13 | NA | 57.26 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Nutriband Inc | Buy | $68.7M | 3.41% | NA | 0.0% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $101.7B | 171.22% | 20.75 | 32.04% |
![]() Biontech Se | Buy | $27.1B | 487.66% | 160.8 | -18.75% |
![]() Alnylam Pharmaceuticals, Inc. | Buy | $36.5B | 198.57% | NA | -3.11% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $122.9B | 136.25% | 32.84 | -4.74% |
Insights on Nutriband Inc
Revenue is up for the last 2 quarters, 408.53K → 442.83K (in $), with an average increase of 7.8% per quarter
Netprofit is up for the last 2 quarters, -1.89M → -1.70M (in $), with an average increase of 11.3% per quarter
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 63.4% return, outperforming this stock by 61.5%
Vanguard Group Inc
Geode Capital Management, LLC
Millennium Management LLC
State Street Corp
Atria Wealth Solutions, Inc.
Morgan Stanley - Brokerage Accounts
nutriband inc. is a health and pharmaceutical company based in, oviedo, florida. nutriband's primary focus is on transdermal and topical technologies for product development.
Organization | Nutriband Inc |
Employees | 0 |
CEO | Mr. Serguei Melnik |
Industry | Health Technology |
Victoryshares International
$5.93
-4.2%
Clearbridge Focus Value Esg Etf
$5.93
-4.2%
Cabana Target Drawdwn 10 Etf
$5.93
-4.2%
Spdr Nyse Technology Etf
$5.93
-4.2%
Global Ship Lease Inc-cl A
$5.93
-4.2%
Standard Motor Products Inc
$5.93
-4.2%
Cp High Yield Trend Etf
$5.93
-4.2%
Gain Therapeutics Inc
$5.93
-4.2%
Olaplex Holdings, Inc.
$5.93
-4.2%